CurrentRheuma
Get Weekly

Topic · page 14 of 17

Systemic sclerosis & Raynaud's

Limited and diffuse systemic sclerosis, skin, lung (interstitial lung disease), pulmonary arterial hypertension, heart, gut and kidney involvement in systemic sclerosis, digital ulcers, primary and secondary Raynaud's phenomenon, very early systemic sclerosis

Briefs 521–560 of 671 placed here, newest publication first

Briefs in Systemic sclerosis & Raynaud's

Newest publication first

  1. Ann Rheum Dis

    Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups

    Mechanistic study

  2. Clin Exp Rheumatol

    Screening for pulmonary arterial hypertension in patients with systemic sclerosis in the era of new pulmonary arterial hypertension definitions

    Diagnostic or prognostic study

  3. Arthritis Care Res (Hoboken)

    Risk of Malnutrition in Patients With Systemic Sclerosis‐Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo‐Controlled SENSCIS Trial

    Secondary analysis

  4. RMD Open

    Transcutaneous auricular branch vagal nerve stimulation as a non-invasive add-on therapeutic approach for pain in systemic sclerosis

    Randomized controlled trial

  5. Clin Exp Rheumatol

    Interstitial lung disease in patients with systemic sclerosis: what can we learn from the SENSCIS trial?

    Randomized controlled trial

  6. Clin Exp Rheumatol

    Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survival

    Cohort study

  7. RMD Open

    Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis

    Mechanistic study

  8. Clin Exp Rheumatol

    Interleukin-6 serum levels are associated with disease features and cardiovascular risk in patients with systemic sclerosis

    Cross-sectional study

  9. Arthritis Rheumatol

    Cell Type–Specific Biomarkers of Systemic Sclerosis Disease Severity Capture Cell‐Intrinsic and Cell‐Extrinsic Circuits

    Mechanistic study

  10. Rheumatology (Oxford)

    Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud’s Phenomenon (ASRAP) questionnaire

    Diagnostic or prognostic study

  11. Rheumatology (Oxford)

    Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry

    Cohort study

  12. Arthritis Res Ther

    Anti-carbamylated protein antibodies in systemic sclerosis

    Cross-sectional study

  13. Clin Exp Rheumatol

    Exploratory study on quantitative assessment of skin hardness in patients with systemic sclerosis using SOFTGRAM

    Research article

  14. Rheumatology (Oxford)

    Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis

    Cohort study

  15. Rheumatology (Oxford)

    Early initiation of angiotensin-converting enzyme inhibitor in patients with scleroderma renal crisis: a nationwide inpatient database study

    Cohort study

  16. RMD Open

    Microvascular damage in autoimmune connective tissue diseases: a capillaroscopic analysis from 20 years of experience in a EULAR training and research referral centre for imaging

    Cohort study

  17. Scand J Rheumatol

    Systemic sclerosis: changes in the incidence rates in the Finnish population during the years 1999–2018

    Cohort study

  18. Rheumatology (Oxford)

    Performance of serum biomarkers reflective of different pathogenic processes in systemic sclerosis-associated interstitial lung disease

    Cohort study

  19. Rheumatology (Oxford)

    Assessment of digital perfusion as a surrogate outcome in Raynaud’s phenomenon clinical trials

    Diagnostic or prognostic study

  20. Ann Rheum Dis

    Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosis

    Mechanistic study

  21. Clin Exp Rheumatol

    Detection of IgE-autoantibodies to nuclear antigens in patients with systemic sclerosis and analysis of their clinical relevance

    Cross-sectional study

  22. Arthritis Rheumatol

    Amelioration of Fibrotic Remodeling of Human 3‐Dimensional Full‐Thickness Skin by Transglutamase 2 Inhibition

    Mechanistic study

  23. Rheumatology (Oxford)

    Lung ultrasound compared to computed tomography detection and automated quantification of systemic sclerosis-associated interstitial lung disease: preliminary study

    Diagnostic or prognostic study

  24. Clin Exp Rheumatol

    Could the IgA isotype provide additional information in systemic sclerosis patients? A retrospective study entailing IgA isotyping in a Mediterranean systemic sclerosis cohort

    Cross-sectional study

  25. Semin Arthritis Rheum

    Sudden cardiac death, arrhythmias and abnormal electrocardiography in systemic sclerosis: A systematic review and meta-analysis

    Meta-analysis

  26. Rheumatology (Oxford)

    Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review

    Cohort study

  27. Arthritis Rheumatol

    Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis

    Randomized controlled trial

  28. Clin Exp Rheumatol

    Long-term organ damage accrual and late mortality in systemic sclerosis

    Cohort study

  29. Rheumatology (Oxford)

    Increased CD8+ tissue resident memory T cells, regulatory T cells and activated natural killer cells in systemic sclerosis lungs

    Mechanistic study

  30. Rheumatology (Oxford)

    Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease

    Secondary analysis

  31. Semin Arthritis Rheum

    Increased oxidative stress response in circulating blood of systemic sclerosis patients – relation to disease characteristics and inflammatory blood biomarkers

    Case-control study

  32. Arthritis Care Res (Hoboken)

    Validity, Reliability, and Differential Item Functioning of English and French Versions of the 10‐Item Connor‐Davidson Resilience Scale in Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study

    Diagnostic or prognostic study

  33. Rheumatology (Oxford)

    Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort

    Secondary analysis

  34. Rheumatology (Oxford)

    The presence of abnormal septal motion on echocardiography is a predictor of abnormal cardiac magnetic resonance in systemic sclerosis

    Cohort study

  35. Rheumatology (Oxford)

    Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades

    Cohort study

  36. Arthritis Res Ther

    Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis

    Cross-sectional study

  37. Arthritis Rheumatol

    A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis

    Randomized controlled trial

  38. Arthritis Rheumatol

    A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis–Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study

    Diagnostic or prognostic study

  39. Arthritis Res Ther

    Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis

    Cohort study

  40. Rheumatology (Oxford)

    Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis

    Cohort study

All 671 Briefs in ExploreShowing Briefs 521–560 of 671, newest first